The functions of Core Unit A are as follows: 1) To provide all the administrative and fiscal services that are required for support of the research activities of the Projects and the Core Units; 2) To coordinate all the clinical regulatory activities of all the components of the Program Project; 3) To interact with US Federal, Greek, EU and local regulatory agencies, as required; 4) To organize all the communications between components of the Program Project; 5) To coordinate and support the activities of the Internal and External Advisory committees 6) To organize and coordinate the scholarly activities of the Program Project including biweekly teleconference-lab meetings of the Seattle-New York-Thessaloniki investigators, 7) To organize the bimonthly evaluation and planning meetings of the executive committee of the Program Project. 8) To coordinate the fulfillment by all components of the Program Project of administrative requirements concerning biosafety, animal welfare etc 9) To assist the Principal Investigator in preparation of reports to NIH, the NHLBI DSMB and other agencies, as required.
| Constantinou, Varnavas C; Bouinta, Asimina; Karponi, Garyfalia et al. (2017) Poor stem cell harvest may not always be related to poor mobilization: lessons gained from a mobilization study in patients with ?-thalassemia major. Transfusion 57:1031-1039 |
| Gori, Jennifer L; Butler, Jason M; Kunar, Balvir et al. (2017) Endothelial Cells Promote Expansion of Long-Term Engrafting Marrow Hematopoietic Stem and Progenitor Cells in Primates. Stem Cells Transl Med 6:864-876 |
| Psatha, Nikoletta; Karponi, Garyfalia; Yannaki, Evangelia (2016) Optimizing autologous cell grafts to improve stem cell gene therapy. Exp Hematol 44:528-39 |
| Li, Li B; Ma, Chao; Awong, Geneve et al. (2016) Silent IL2RG Gene Editing in Human Pluripotent Stem Cells. Mol Ther 24:582-91 |
| Karponi, Garyfalia; Psatha, Nikoletta; Lederer, Carsten Werner et al. (2015) Plerixafor+G-CSF-mobilized CD34+ cells represent an optimal graft source for thalassemia gene therapy. Blood 126:616-9 |
| Vierstra, Jeff; Reik, Andreas; Chang, Kai-Hsin et al. (2015) Functional footprinting of regulatory DNA. Nat Methods 12:927-30 |
| Qi, Heyuan; Liu, Mingdong; Emery, David W et al. (2015) Functional validation of a constitutive autonomous silencer element. PLoS One 10:e0124588 |
| Liu, Mingdong; Maurano, Matthew T; Wang, Hao et al. (2015) Genomic discovery of potent chromatin insulators for human gene therapy. Nat Biotechnol 33:198-203 |
| Polak, Paz; Karli?, Rosa; Koren, Amnon et al. (2015) Cell-of-origin chromatin organization shapes the mutational landscape of cancer. Nature 518:360-364 |
| Chandrasekaran, Devikha; Nakamoto, Betty; Watts, Korashon L et al. (2014) Modeling promising nonmyeloablative conditioning regimens in nonhuman primates. Hum Gene Ther 25:1013-22 |
Showing the most recent 10 out of 161 publications
